[Zolbetuximab (gastric or gastro-oesophageal junction adenocarcinoma, HER2-negative) – Assessment in accordance with § 35a Social Code Book (SGB) V (1), Sentence 11]

Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen
Record ID 32018013874
German
Original Title: Zolbetuximab (Adenokarzinom des Magens oder des gastroösophagealen Übergangs)
Details
Project Status: Completed
Year Published: 2025
English language abstract: There is no English language summary available
Publication Type: Full HTA
Country: Germany
MeSH Terms
  • Stomach Neoplasms
  • Esophageal Neoplasms
  • Antibodies, Monoclonal
Keywords
  • Zolbetuximab
  • Stomach Neoplasms
  • Esophageal Neoplasms
  • Health Care Costs
  • Epidemiology
Contact
Organisation Name: Institute for Quality and Efficiency in Health Care (IQWiG)
Contact Address: IQWiG, Siegburger Str. 237, 50679 Cologne, GERMANY, Tel: +49(0)221-35685, Fax: +49(0)221-356851
Contact Email: berichte@iqwig.de
Copyright: Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.